ArticleMolecular therapy : the journal of the American Society of Gene Therapy2021

Targeted In Vivo Delivery of NF-κB Decoy Inhibitor Augments Sensitivity of B Cell Lymphoma to Therapy.

Zhuoran Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.